1. Home
  2. LGND vs CNO Comparison

LGND vs CNO Comparison

Compare LGND & CNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • CNO
  • Stock Information
  • Founded
  • LGND 1987
  • CNO 1979
  • Country
  • LGND United States
  • CNO United States
  • Employees
  • LGND 68
  • CNO N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • CNO Accident &Health Insurance
  • Sector
  • LGND Health Care
  • CNO Finance
  • Exchange
  • LGND Nasdaq
  • CNO Nasdaq
  • Market Cap
  • LGND 3.2B
  • CNO 3.8B
  • IPO Year
  • LGND 1992
  • CNO 1987
  • Fundamental
  • Price
  • LGND $184.44
  • CNO $40.18
  • Analyst Decision
  • LGND Strong Buy
  • CNO Hold
  • Analyst Count
  • LGND 8
  • CNO 5
  • Target Price
  • LGND $144.71
  • CNO $43.60
  • AVG Volume (30 Days)
  • LGND 139.7K
  • CNO 496.2K
  • Earning Date
  • LGND 08-05-2025
  • CNO 11-03-2025
  • Dividend Yield
  • LGND N/A
  • CNO 1.69%
  • EPS Growth
  • LGND N/A
  • CNO N/A
  • EPS
  • LGND N/A
  • CNO 2.77
  • Revenue
  • LGND $181,488,000.00
  • CNO $4,382,400,000.00
  • Revenue This Year
  • LGND $18.41
  • CNO N/A
  • Revenue Next Year
  • LGND $18.87
  • CNO $3.27
  • P/E Ratio
  • LGND N/A
  • CNO $14.37
  • Revenue Growth
  • LGND 53.40
  • CNO 0.96
  • 52 Week Low
  • LGND $81.74
  • CNO $34.36
  • 52 Week High
  • LGND $129.90
  • CNO $43.20
  • Technical
  • Relative Strength Index (RSI)
  • LGND 58.00
  • CNO 56.06
  • Support Level
  • LGND $182.87
  • CNO $39.62
  • Resistance Level
  • LGND $194.44
  • CNO $40.32
  • Average True Range (ATR)
  • LGND 5.35
  • CNO 0.70
  • MACD
  • LGND -0.77
  • CNO 0.05
  • Stochastic Oscillator
  • LGND 40.05
  • CNO 86.37

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About CNO CNO Financial Group Inc.

CNO Financial Group Inc is a holding company for a group of insurance companies that offers middle-income American consumers insurance and securities products through exclusive agents, independent producers, and direct marketing. Consumers are served through the phone, online, mail, face-to-face with agents, or sales channels. The company's operating segments include annuity, health, and life insurance product lines as well as the investment and fee revenue segments. Maximum revenue is generated from the health product line segment. Annuity premiums account for the majority of the total premiums collected. Annuity products include fixed index annuities, traditional fixed-rate annuities, and single-premium immediate annuity products.

Share on Social Networks: